Necrolytic migratory erythaema and glucagonoma syndrome

Acta Clinica Belgica

Volumn 64, Issue 1, 2009, Pages 70-71

  Marogy, G ^a   De Man, M ^b   Verslype, C ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b OLV HOSPITAL   (Belgium)

Author keywords

Glucagonoma syndrome; Necrolytic migratory erythaema

Indexed keywords

DOXORUBICIN; OCTREOTIDE;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CONTROLLED DRUG RELEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ERYTHEMA; ESOPHAGOGASTRODUODENOSCOPY; FATIGUE; FEMALE; FOLLOW UP; GLUCAGONOMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLUCAGONEMIA; LIVER METASTASIS; NECROLYTIC MIGRATORY ERYTHEMA; PANCREAS RESECTION; PATHOGENESIS; RASH; REFLUX ESOPHAGITIS; SPLENECTOMY; WEIGHT REDUCTION;

EID: 61349104270     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2009.014     Document Type: Article

References (3)

1. Pujol RM, Wang CY, el-Azhary RA, Su WP, Gibson LE, Schroeter AL Necrolytic migratory erythema: clinicopathologic study of 13 cases. Int J Dermatol 2004 Jan;43(1):12-8.
2. Tierney EP, Badger J. Etiology and pathogenesis of necrolytic migratory erythema: review of the literatu re. Med Gen Med 2004 Sep 10;6(3):4.
3. Remes-Troche JM, García-de-Acevedo B, Zuñiga-Varga J, Avila-Funes A, Orozco-Topete R. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome J Eur Acad Dermatol Venereol 2004 Sep;18(5):591-5.